Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00124059
Status:
COMPLETED
Last Update Posted:
2015-10-06
First Post:
2005-07-22
Brief Title:
Quetiapine Fumarate Seroquel for the Treatment of Alcohol Dependence
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
A Double-Blind Study of Quetiapine Fumarate Seroquel for the Treatment of Type A vsType B Alcoholics
Status:
COMPLETED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether seroquel is effective in the treatment of type A and type B alcohol dependence
Detailed Description:
The purpose of this study is to obtain preliminary data regarding the safety efficacy and tolerability of quetiapine Seroquel SQL in treating Type A vs B alcohol dependent outpatients seeking treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None